Mangrove Partners’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-175,347
| Closed | -$5.94M | – | 263 |
|
|
2022
Q4 | $5.94M | Hold |
175,347
| – | – | 0.34% | 80 |
|
|
2022
Q3 | $8.63M | Sell |
175,347
-66,667
| -28% | -$3.28M | 0.5% | 60 |
|
|
2022
Q2 | $9.51M | Buy |
+242,014
| New | +$9.51M | 0.47% | 46 |
|
|
2021
Q1 | – | Sell |
-23,522
| Closed | -$2.14M | – | 323 |
|
|
2020
Q4 | $2.14M | Sell |
23,522
-169,364
| -88% | -$15.4M | 0.29% | 61 |
|
|
2020
Q3 | $9.49M | Sell |
192,886
-25,340
| -12% | -$1.25M | 1.2% | 23 |
|
|
2020
Q2 | $18.6M | Buy |
218,226
+33,264
| +18% | +$2.83M | 4.54% | 7 |
|
|
2020
Q1 | $13.4M | Buy |
184,962
+9,811
| +6% | +$709K | 1.84% | 17 |
|
|
2019
Q4 | $12.5M | Buy |
+175,151
| New | +$12.5M | 1.83% | 18 |
|